Drug Development Technology Leader Arisglobal Completes Acquisition Of Amplexor Life Sciences
Acquiring Company
ArisGlobal
Acquired Company
Amplexor Life Sciences
WalthamSoftwareScience And EngineeringDescription
ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, today announces the completion of its acquisition of Amplexor Life Sciences. This deal will deliver the most intelligent, connected, and comprehensive regulatory platform available, bringing increased efficiency for life sciences organizations as they bring new therapies to market.
Other recent acquisitions in Science And Engineering and Software
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Arisglobal Acquires Leading Regulatory Data Solution Sporify (May 16, 2023)
- Zone & Co Announces Acquisition Of Renowned Oracle Netsuite Partner Infinet Cloud (May 24, 2023)
- Blend360 Acquires Futureproofai, Inc., Further Enhancing Customer Decision Hub Implementations With Advanced Data And Analytics Expertise (May 23, 2023)
- Xtend Announces Acquisition Of Leading Drone Inspection Specialists Performance Rotors (May 18, 2023)
- Qlik Acquires Talend, Combining Its Best-In-Class Data Integration With Talend’S Leading Data Transformation, Quality, And Governance Capabilities (May 16, 2023)
- Onemagnify Acquires Rxa To Extend Data-Driven Solutions Capabilities (May 11, 2023)
Who to call at ArisGlobal, and when
When ArisGlobal changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ArisGlobal raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ArisGlobal, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ArisGlobal. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ArisGlobal makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Amplexor Life Sciences?
Amplexor Life Sciences was acquired by ArisGlobal, based in Waltham. The deal was reported on April 20, 2023. ArisGlobal is the market leader in drug safety solutions worldwide and is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. ArisGlobal is privately held and operates in Software.
When did ArisGlobal acquire Amplexor Life Sciences?
ArisGlobal's acquisition of Amplexor Life Sciences was reported on April 20, 2023. ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, today announces the completion of its acquisition of Amplexor Life Sciences. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Amplexor Life Sciences do?
Amplexor Life Sciences is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.